R Loops and Links to Human Disease

Journal of Molecular Biology

Volumn 429, Issue 21, 2017, Pages 3168-3180

  Richard, Patricia ^a   Manley, James L ^a  

^a Columbia University ^*  (United States)

Author keywords

chromatin reorganization; genomic instability; human diseases; R loops; transcription

Indexed keywords

ATAXIN 2; DNA; RNA;

AMYOTROPHIC LATERAL SCLEROSIS; CHROMOSOME REARRANGEMENT; DOUBLE STRANDED DNA BREAK; FRAGILE X SYNDROME; FRIEDREICH ATAXIA; FRONTOTEMPORAL DEMENTIA; GENE LOCUS; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; HUNTINGTON CHOREA; MALIGNANT NEOPLASM; MYOTONIC DYSTROPHY; NONHUMAN; NUCLEIC ACID STRUCTURE; PRIORITY JOURNAL; R LOOP; REVIEW; SPINOCEREBELLAR DEGENERATION; TRANSCRIPTION REGULATION; TRINUCLEOTIDE REPEAT; CONFORMATION; DISEASES; DNA REPLICATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS;

DISEASE; DNA REPLICATION; GENE EXPRESSION REGULATION; GENOMIC INSTABILITY; HUMANS; NUCLEIC ACID CONFORMATION; TRANSCRIPTION, GENETIC;

EID: 84997223850     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2016.08.031     Document Type: Review

References (170)

1. Aguilera, A., Garcia-Muse, T., R loops: from transcription byproducts to threats to genome stability. Mol. Cell 46 (2012), 115–124.
2. Drolet, M., Bi, X., Liu, L.F., Hypernegative supercoiling of the DNA template during transcription elongation in vitro. J. Biol. Chem. 269 (1994), 2068–2074.
3. Ginno, P.A., Lott, P.L., Christensen, H.C., Korf, I., Chedin, F., R-loop formation is a distinctive characteristic of unmethylated human CpG island promoters. Mol. Cell 45 (2012), 814–825.
4. Ginno, P.A., Lim, Y.W., Lott, P.L., Korf, I., Chedin, F., GC skew at the 5′ and 3′ ends of human genes links R-loop formation to epigenetic regulation and transcription termination. Genome Res. 23 (2013), 1590–1600.
5. Chan, Y.A., Aristizabal, M.J., Lu, P.Y., Luo, Z., Hamza, A., Kobor, M.S., et al. Genome-wide profiling of yeast DNA:RNA hybrid prone sites with DRIP-chip. PLoS Genet., 10, 2014, e1004288.
6. Wahba, L., Costantino, L., Tan, F.J., Zimmer, A., Koshland, D., S1-DRIP-seq identifies high expression and polyA tracts as major contributors to R-loop formation. Genes Dev. 30 (2016), 1327–1338.
7. Sanz, L.A., Hartono, S.R., Lim, Y.W., Steyaert, S., Rajpurkar, A., Ginno, P.A., et al. Prevalent, dynamic, and conserved R-loop structures associate with specific epigenomic signatures in mammals. Mol. Cell 63 (2016), 167–178.
8. Yu, K., Chedin, F., Hsieh, C.L., Wilson, T.E., Lieber, M.R., R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nat. Immunol. 4 (2003), 442–451.
9. Xu, B., Clayton, D.A., RNA–DNA hybrid formation at the human mitochondrial heavy-strand origin ceases at replication start sites: an implication for RNA–DNA hybrids serving as primers. EMBO J. 15 (1996), 3135–3143.
10. Pohjoismaki, J.L., Holmes, J.B., Wood, S.R., Yang, M.Y., Yasukawa, T., Reyes, A., et al. Mammalian mitochondrial DNA replication intermediates are essentially duplex but contain extensive tracts of RNA/DNA hybrid. J. Mol. Biol. 397 (2010), 1144–1155.
11. Skourti-Stathaki, K., Proudfoot, N.J., Gromak, N., Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination. Mol. Cell 42 (2011), 794–805.
12. Skourti-Stathaki, K., Kamieniarz-Gdula, K., Proudfoot, N.J., R-loops induce repressive chromatin marks over mammalian gene terminators. Nature 516 (2014), 436–439.
13. Sollier, J., Stork, C.T., Garcia-Rubio, M.L., Paulsen, R.D., Aguilera, A., Cimprich, K.A., Transcription-coupled nucleotide excision repair factors promote R-loop-induced genome instability. Mol. Cell 56 (2014), 777–785.
14. Li, X., Manley, J.L., Cotranscriptional processes and their influence on genome stability. Genes Dev. 20 (2006), 1838–1847.
15. Skourti-Stathaki, K., Proudfoot, N.J., A double-edged sword: R loops as threats to genome integrity and powerful regulators of gene expression. Genes Dev. 28 (2014), 1384–1396.
16. Sollier, J., Cimprich, K.A., Breaking bad: R-loops and genome integrity. Trends Cell Biol. 25 (2015), 514–522.
17. Santos-Pereira, J.M., Aguilera, A., R loops: new modulators of genome dynamics and function. Nat. Rev. Genet. 16 (2015), 583–597.
18. Hamperl, S., Cimprich, K.A., The contribution of co-transcriptional RNA:DNA hybrid structures to DNA damage and genome instability. DNA Repair 19 (2014), 84–94.
19. Groh, M., Gromak, N., Out of balance: R-loops in human disease. PLoS Genet., 10, 2014, e1004630.
20. Huertas, P., Aguilera, A., Cotranscriptionally formed DNA:RNA hybrids mediate transcription elongation impairment and transcription-associated recombination. Mol. Cell 12 (2003), 711–721.
21. Dominguez-Sanchez, M.S., Barroso, S., Gomez-Gonzalez, B., Luna, R., Aguilera, A., Genome instability and transcription elongation impairment in human cells depleted of THO/TREX. PLoS Genet., 7, 2011, e1002386.
22. Li, X., Manley, J.L., Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell 122 (2005), 365–378.
23. Wahba, L., Amon, J.D., Koshland, D., Vuica-Ross, M., RNase H and multiple RNA biogenesis factors cooperate to prevent RNA:DNA hybrids from generating genome instability. Mol. Cell 44 (2011), 978–988.
24. Paulsen, R.D., Soni, D.V., Wollman, R., Hahn, A.T., Yee, M.C., Guan, A., et al. A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability. Mol. Cell 35 (2009), 228–239.
25. Stirling, P.C., Chan, Y.A., Minaker, S.W., Aristizabal, M.J., Barrett, I., Sipahimalani, P., et al. R-loop-mediated genome instability in mRNA cleavage and polyadenylation mutants. Genes Dev. 26 (2012), 163–175.
26. Li, X., Niu, T., Manley, J.L., The RNA binding protein RNPS1 alleviates ASF/SF2 depletion-induced genomic instability. RNA 13 (2007), 2108–2115.
27. Basu, U., Meng, F.L., Keim, C., Grinstein, V., Pefanis, E., Eccleston, J., et al. The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates. Cell 144 (2011), 353–363.
28. Tuduri, S., Crabbe, L., Conti, C., Tourriere, H., Holtgreve-Grez, H., Jauch, A., et al. Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription. Nat. Cell Biol. 11 (2009), 1315–1324.
29. El Hage, A., French, S.L., Beyer, A.L., Tollervey, D., Loss of topoisomerase I leads to R-loop-mediated transcriptional blocks during ribosomal RNA synthesis. Genes Dev. 24 (2010), 1546–1558.
30. Tourriere, H., Pasero, P., Maintenance of fork integrity at damaged DNA and natural pause sites. DNA Repair 6 (2007), 900–913.
31. Castellano-Pozo, M., Garcia-Muse, T., Aguilera, A., R-loops cause replication impairment and genome instability during meiosis. EMBO Rep. 13 (2012), 923–929.
32. Gan, W., Guan, Z., Liu, J., Gui, T., Shen, K., Manley, J.L., et al. R-loop-mediated genomic instability is caused by impairment of replication fork progression. Genes Dev. 25 (2011), 2041–2056.
33. Wellinger, R.E., Prado, F., Aguilera, A., Replication fork progression is impaired by transcription in hyperrecombinant yeast cells lacking a functional THO complex. Mol. Cell. Biol. 26 (2006), 3327–3334.
34. Herrera-Moyano, E., Mergui, X., Garcia-Rubio, M.L., Barroso, S., Aguilera, A., The yeast and human FACT chromatin-reorganizing complexes solve R-loop-mediated transcription-replication conflicts. Genes Dev. 28 (2014), 735–748.
35. Helmrich, A., Ballarino, M., Tora, L., Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Mol. Cell 44 (2011), 966–977.
36. Pearson, C.E., Nichol Edamura, K., Cleary, J.D., Repeat instability: mechanisms of dynamic mutations. Nat. Rev. Genet. 6 (2005), 729–742.
37. Lopez Castel, A., Cleary, J.D., Pearson, C.E., Repeat instability as the basis for human diseases and as a potential target for therapy. Nat. Rev. Mol. Cell Biol. 11 (2010), 165–170.
38. McIvor, E.I., Polak, U., Napierala, M., New insights into repeat instability: role of RNA*DNA hybrids. RNA Biol. 7 (2010), 551–558.
39. Reddy, K., Tam, M., Bowater, R.P., Barber, M., Tomlinson, M., Nichol Edamura, K., et al. Determinants of R-loop formation at convergent bidirectionally transcribed trinucleotide repeats. Nucleic Acids Res. 39 (2011), 1749–1762.
40. Grabczyk, E., Mancuso, M., Sammarco, M.C., A persistent RNA.DNA hybrid formed by transcription of the Friedreich ataxia triplet repeat in live bacteria, and by T7 RNAP in vitro. Nucleic Acids Res. 35 (2007), 5351–5359.
41. Lin, Y., Dent, S.Y., Wilson, J.H., Wells, R.D., Napierala, M., R loops stimulate genetic instability of CTG.CAG repeats. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 692–697.
42. Bowater, R.P., Jaworski, A., Larson, J.E., Parniewski, P., Wells, R.D., Transcription increases the deletion frequency of long CTG.CAG triplet repeats from plasmids in Escherichia coli. Nucleic Acids Res. 25 (1997), 2861–2868.
43. Jung, J., Bonini, N., CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease. Science (New York, N.Y.), 315 (2007), 1857–1859.
44. Nakamori, M., Pearson, C.E., Thornton, C.A., Bidirectional transcription stimulates expansion and contraction of expanded (CTG)*(CAG) repeats. Hum. Mol. Genet. 20 (2011), 580–588.
45. Batra, R., Charizanis, K., Swanson, M.S., Partners in crime: bidirectional transcription in unstable microsatellite disease. Hum. Mol. Genet. 19 (2010), R77–R82.
46. Lin, Y., Leng, M., Wan, M., Wilson, J.H., Convergent transcription through a long CAG tract destabilizes repeats and induces apoptosis. Mol. Cell. Biol. 30 (2010), 4435–4451.
47. Lin, Y., Wilson, J.H., Nucleotide excision repair, mismatch repair, and R-loops modulate convergent transcription-induced cell death and repeat instability. PLoS One, 7, 2012, e46807.
48. Reddy, K., Schmidt, M.H., Geist, J.M., Thakkar, N.P., Panigrahi, G.B., Wang, Y.H., et al. Processing of double-R-loops in (CAG).(CTG) and C9orf72 (GGGGCC).(GGCCCC) repeats causes instability. Nucleic Acids Res. 42 (2014), 10,473–10,487.
49. Groh, M., Lufino, M.M., Wade-Martins, R., Gromak, N., R-loops associated with triplet repeat expansions promote gene silencing in Friedreich ataxia and fragile X syndrome. PLoS Genet., 10, 2014, e1004318.
50. Wells, R.D., DNA triplexes and Friedreich ataxia. FASEB J. 22 (2008), 1625–1634.
51. Tous, C., Aguilera, A., Impairment of transcription elongation by R-loops in vitro. Biochem. Biophys. Res. Commun. 360 (2007), 428–432.
52. Santoro, M.R., Bray, S.M., Warren, S.T., Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu. Rev. Pathol. 7 (2012), 219–245.
53. Usdin, K., Kumari, D., Repeat-mediated epigenetic dysregulation of the FMR1 gene in the fragile X-related disorders. Front. Genet., 6, 2015, 192.
54. Hagerman, P., Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms. Acta Neuropathol. 126 (2013), 1–19.
55. Loomis, E.W., Sanz, L.A., Chedin, F., Hagerman, P.J., Transcription-associated R-loop formation across the human FMR1 CGG-repeat region. PLoS Genet., 10, 2014, e1004294.
56. Colak, D., Zaninovic, N., Cohen, M.S., Rosenwaks, Z., Yang, W.Y., Gerhardt, J., et al. Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome. Science (New York, N.Y.), 343 (2014), 1002–1005.
57. Eiges, R., Urbach, A., Malcov, M., Frumkin, T., Schwartz, T., Amit, A., et al. Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 1 (2007), 568–577.
58. Zumwalt, M., Ludwig, A., Hagerman, P.J., Dieckmann, T., Secondary structure and dynamics of the r(CGG) repeat in the mRNA of the fragile X mental retardation 1 (FMR1) gene. RNA Biol. 4 (2007), 93–100.
59. Duquette, M.L., Handa, P., Vincent, J.A., Taylor, A.F., Maizels, N., Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA. Genes Dev. 18 (2004), 1618–1629.
60. Gellert, M., Lipsett, M.N., Davies, D.R., Helix formation by guanylic acid. Proc. Natl. Acad. Sci. U. S. A. 48 (1962), 2013–2018.
61. Huppert, J.L., Bugaut, A., Kumari, S., Balasubramanian, S., G-quadruplexes: the beginning and end of UTRs. Nucleic Acids Res. 36 (2008), 6260–6268.
62. Eddy, J., Maizels, N., Conserved elements with potential to form polymorphic G-quadruplex structures in the first intron of human genes. Nucleic Acids Res. 36 (2008), 1321–1333.
63. Haeusler, A.R., Donnelly, C.J., Periz, G., Simko, E.A., Shaw, P.G., Kim, M.S., et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507 (2014), 195–200.
64. Powell, W.T., Coulson, R.L., Gonzales, M.L., Crary, F.K., Wong, S.S., Adams, S., et al. R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 13,938–13,943.
65. Boque-Sastre, R., Soler, M., Oliveira-Mateos, C., Portela, A., Moutinho, C., Sayols, S., et al. Head-to-head antisense transcription and R-loop formation promotes transcriptional activation. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 5785–5790.
66. Castellano-Pozo, M., Santos-Pereira, J.M., Rondon, A.G., Barroso, S., Andujar, E., Perez-Alegre, M., et al. R loops are linked to histone H3 S10 phosphorylation and chromatin condensation. Mol. Cell 52 (2013), 583–590.
67. Negrini, S., Gorgoulis, V.G., Halazonetis, T.D., Genomic instability—an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 11 (2010), 220–228.
68. Loeb, L.A., Human cancers express mutator phenotypes: origin, consequences and targeting. Nat. Rev. Cancer 11 (2011), 450–457.
69. Schvartzman, J.M., Sotillo, R., Benezra, R., Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat. Rev. Cancer 10 (2010), 102–115.
70. Gorgoulis, V.G., Vassiliou, L.V., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434 (2005), 907–913.
71. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (New York, N.Y.) 266 (1994), 66–71.
72. Schlacher, K., Wu, H., Jasin, M., A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. Cancer Cell 22 (2012), 106–116.
73. Ford, D., Easton, D.F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am. J. Hum. Genet. 62 (1998), 676–689.
74. Savage, K.I., Gorski, J.J., Barros, E.M., Irwin, G.W., Manti, L., Powell, A.J., et al. Identification of a BRCA1-mRNA splicing complex required for efficient DNA repair and maintenance of genomic stability. Mol. Cell 54 (2014), 445–459.
75. Hill, S.J., Rolland, T., Adelmant, G., Xia, X., Owen, M.S., Dricot, A., et al. Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage. Genes Dev. 28 (2014), 1957–1975.
76. Bhatia, V., Barroso, S.I., Garcia-Rubio, M.L., Tumini, E., Herrera-Moyano, E., Aguilera, A., BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2. Nature 511 (2014), 362–365.
77. Hatchi, E., Skourti-Stathaki, K., Ventz, S., Pinello, L., Yen, A., Kamieniarz-Gdula, K., et al. BRCA1 recruitment to transcriptional pause sites is required for R-loop-driven DNA damage repair. Mol. Cell 57 (2015), 636–647.
78. Cools, J., DeAngelo, D.J., Gotlib, J., Stover, E.H., Legare, R.D., Cortes, J., et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N. Engl. J. Med. 348 (2003), 1201–1214.
79. Chernikova, S.B., Razorenova, O.V., Higgins, J.P., Sishc, B.J., Nicolau, M., Dorth, J.A., et al. Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability. Cancer Res. 72 (2012), 2111–2119.
80. Shema, E., Tirosh, I., Aylon, Y., Huang, J., Ye, C., Moskovits, N., et al. The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes Dev. 22 (2008), 2664–2676.
81. Chen, W.D., Han, Z.J., Skoletsky, J., Olson, J., Sah, J., Myeroff, L., et al. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J. Natl. Cancer Inst. 97 (2005), 1124–1132.
82. Yang, Y., McBride, K.M., Hensley, S., Lu, Y., Chedin, F., Bedford, M.T., Arginine methylation facilitates the recruitment of TOP3B to chromatin to prevent R loop accumulation. Mol. Cell 53 (2014), 484–497.
83. Kuppers, R., Dalla-Favera, R., Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20 (2001), 5580–5594.
84. Shou, Y., Martelli, M.L., Gabrea, A., Qi, Y., Brents, L.A., Roschke, A., et al. Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 228–233.
85. Ruiz, J.F., Gomez-Gonzalez, B., Aguilera, A., AID induces double-strand breaks at immunoglobulin switch regions and c-MYC causing chromosomal translocations in yeast THO mutants. PLoS Genet., 7, 2011, e1002009.
86. Kee, Y., D'Andrea, A.D., Molecular pathogenesis and clinical management of Fanconi anemia. J. Clin. Invest. 122 (2012), 3799–3806.
87. Schwab, R.A., Nieminuszczy, J., Shah, F., Langton, J., Lopez Martinez, D., Liang, C.C., et al. The Fanconi anemia pathway maintains genome stability by coordinating replication and transcription. Mol. Cell 60 (2015), 351–361.
88. Garcia-Rubio, M.L., Perez-Calero, C., Barroso, S.I., Tumini, E., Herrera-Moyano, E., Rosado, I.V., et al. The Fanconi anemia pathway protects genome integrity from R-loops. PLoS Genet., 11, 2015, e1005674.
89. Wu, Y., Shin-ya, K., Brosh, R.M. Jr., FANCJ helicase defective in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability. Mol. Cell. Biol. 28 (2008), 4116–4128.
90. Xiao, Y., Chen, J., Liao, Q., Wu, Y., Peng, C., Chen, X., Lytic infection of Kaposi's sarcoma-associated herpesvirus induces DNA double-strand breaks and impairs non-homologous end joining. J. Gen. Virol. 94 (2013), 1870–1875.
91. Pan, H., Zhou, F., Gao, S.J., Kaposi's sarcoma-associated herpesvirus induction of chromosome instability in primary human endothelial cells. Cancer Res. 64 (2004), 4064–4068.
92. Jackson, B.R., Noerenberg, M., Whitehouse, A., A novel mechanism inducing genome instability in Kaposi's sarcoma-associated herpesvirus infected cells. PLoS Pathog., 10, 2014, e1004098.
93. Dominguez-Sanchez, M.S., Saez, C., Japon, M.A., Aguilera, A., Luna, R., Differential expression of THOC1 and ALY mRNP biogenesis/export factors in human cancers. BMC Cancer, 11, 2011, 77.
94. Renton, A.E., Chio, A., Traynor, B.J., State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 17 (2014), 17–23.
95. Haverkamp, L.J., Appel, V., Appel, S.H., Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 118 (1995), 707–719.
96. Kiernan, M.C., Vucic, S., Cheah, B.C., Turner, M.R., Eisen, A., Hardiman, O., et al. Amyotrophic lateral sclerosis. Lancet 377 (2011), 942–955.
97. Salvi, J.S., Mekhail, K., R-loops highlight the nucleus in ALS. Nucleus 6 (2015), 23–29.
98. DeJesus-Hernandez, M., Mackenzie, I.R., Boeve, B.F., Boxer, A.L., Baker, M., Rutherford, N.J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72 (2011), 245–256.
99. Renton, A.E., Majounie, E., Waite, A., Simon-Sanchez, J., Rollinson, S., Gibbs, J.R., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72 (2011), 257–268.
100. Majounie, E., Renton, A.E., Mok, K., Dopper, E.G., Waite, A., Rollinson, S., et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 11 (2012), 323–330.
101. Neary, D., Snowden, J.S., Gustafson, L., Passant, U., Stuss, D., Black, S., et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51 (1998), 1546–1554.
102. Rutherford, N.J., Heckman, M.G., Dejesus-Hernandez, M., Baker, M.C., Soto-Ortolaza, A.I., Rayaprolu, S., et al. Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiol. Aging, 33(12), Dec. 2012 2950.e5–2950.e7.
103. Fratta, P., Mizielinska, S., Nicoll, A.J., Zloh, M., Fisher, E.M., Parkinson, G., et al. C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Sci. Rep., 2, 2012, 1016.
104. Ciura, S., Lattante, S., Le Ber, I., Latouche, M., Tostivint, H., Brice, A., et al. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann. Neurol. 74 (2013), 180–187.
105. Waite, A.J., Baumer, D., East, S., Neal, J., Morris, H.R., Ansorge, O., et al. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol. Aging, 35(7), July 2014 1779.e5–1779.e13.
106. Belzil, V.V., Bauer, P.O., Prudencio, M., Gendron, T.F., Stetler, C.T., Yan, I.K., et al. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 126 (2013), 895–905.
107. Xi, Z., Zinman, L., Moreno, D., Schymick, J., Liang, Y., Sato, C., et al. Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. Am. J. Hum. Genet. 92 (2013), 981–989.
108. Liu, E.Y., Russ, J., Wu, K., Neal, D., Suh, E., McNally, A.G., et al. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD. Acta Neuropathol. 128 (2014), 525–541.
109. Russ, J., Liu, E.Y., Wu, K., Neal, D., Suh, E., Irwin, D.J., et al. Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier. Acta Neuropathol. 129 (2015), 39–52.
110. Belzil, V.V., Bauer, P.O., Gendron, T.F., Murray, M.E., Dickson, D., Petrucelli, L., Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients. Brain Res. 1584 (2014), 15–21.
111. Xi, Z., Rainero, I., Rubino, E., Pinessi, L., Bruni, A.C., Maletta, R.G., et al. Hypermethylation of the CpG-island near the C9orf72 G(4)C(2)-repeat expansion in FTLD patients. Hum. Mol. Genet. 23 (2014), 5630–5637.
112. Zu, T., Liu, Y., Banez-Coronel, M., Reid, T., Pletnikova, O., Lewis, J., et al. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), E4968–E4977.
113. Gendron, T.F., Bieniek, K.F., Zhang, Y.J., Jansen-West, K., Ash, P.E., Caulfield, T., et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 126 (2013), 829–844.
114. Mori, K., Arzberger, T., Grasser, F.A., Gijselinck, I., May, S., Rentzsch, K., et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 126 (2013), 881–893.
115. Mizielinska, S., Lashley, T., Norona, F.E., Clayton, E.L., Ridler, C.E., Fratta, P., et al. C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Acta Neuropathol. 126 (2013), 845–857.
116. Lagier-Tourenne, C., Baughn, M., Rigo, F., Sun, S., Liu, P., Li, H.R., et al. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), E4530–E4539.
117. Wang, J., Haeusler, A.R., Simko, E.A., Emerging role of RNA*DNA hybrids in C9orf72-linked neurodegeneration. Cell Cycle 14 (2015), 526–532.
118. Therrien, M., Rouleau, G.A., Dion, P.A., Parker, J.A., Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. PLoS One, 8, 2013, e83450.
119. Sellier, C., Campanari, M.L., Julie Corbier, C., Gaucherot, A., Kolb-Cheynel, I., Oulad-Abdelghani, M., et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 35 (2016), 1276–1297.
120. Mori, K., Weng, S.M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science (New York, N.Y.) 339 (2013), 1335–1338.
121. Ash, P.E., Bieniek, K.F., Gendron, T.F., Caulfield, T., Lin, W.L., Dejesus-Hernandez, M., et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77 (2013), 639–646.
122. He, F., Jones, J.M., Figueroa-Romero, C., Zhang, D., Feldman, E.L., Goutman, S.A., et al. Screening for novel hexanucleotide repeat expansions at ALS- and FTD-associated loci. Neurol. Genet., 2, 2016, e71.
123. Rollinson, S., Halliwell, N., Young, K., Callister, J.B., Toulson, G., Gibbons, L., et al. Analysis of the hexanucleotide repeat in C9ORF72 in Alzheimer's disease. Neurobiol. Aging 2012:33 (1846), e5–e6.
124. Kohli, M.A., John-Williams, K., Rajbhandary, R., Naj, A., Whitehead, P., Hamilton, K., et al. Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians. Neurobiol. Aging, 34(5), May 2013 1519.e5–1519.e12.
125. Majounie, E., Abramzon, Y., Renton, A.E., Perry, R., Bassett, S.S., Pletnikova, O., et al. Repeat expansion in C9ORF72 in Alzheimer's disease. N. Engl. J. Med. 366 (2012), 283–284.
126. Harms, M., Benitez, B.A., Cairns, N., Cooper, B., Cooper, P., Mayo, K., et al. C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease. JAMA Neurol. 70 (2013), 736–741.
127. Hensman Moss, D.J., Poulter, M., Beck, J., Hehir, J., Polke, J.M., Campbell, T., et al. C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology 82 (2014), 292–299.
128. Elden, A.C., Kim, H.J., Hart, M.P., Chen-Plotkin, A.S., Johnson, B.S., Fang, X., et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466 (2010), 1069–1075.
129. van Blitterswijk, M., Mullen, B., Heckman, M.G., Baker, M.C., DeJesus-Hernandez, M., Brown, P.H., et al. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers. Neurobiol. Aging, 35(10), Oct. 2014 2421.e13–2421.e17.
130. Pulst, S.M., Nechiporuk, A., Nechiporuk, T., Gispert, S., Chen, X.N., Lopes-Cendes, I., et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat. Genet. 14 (1996), 269–276.
131. Imbert, G., Saudou, F., Yvert, G., Devys, D., Trottier, Y., Garnier, J.M., et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat. Genet. 14 (1996), 285–291.
132. Sanpei, K., Takano, H., Igarashi, S., Sato, T., Oyake, M., Sasaki, H., et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat. Genet. 14 (1996), 277–284.
133. Farg, M.A., Soo, K.Y., Warraich, S.T., Sundaramoorthy, V., Blair, I.P., Atkin, J.D., Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis. Hum. Mol. Genet. 22 (2013), 717–728.
134. Salvi, J.S., Chan, J.N., Szafranski, K., Liu, T.T., Wu, J.D., Olsen, J.B., et al. Roles for Pbp1 and caloric restriction in genome and lifespan maintenance via suppression of RNA–DNA hybrids. Dev. Cell 30 (2014), 177–191.
135. Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (New York, N.Y.) 314 (2006), 130–133.
136. Colombrita, C., Zennaro, E., Fallini, C., Weber, M., Sommacal, A., Buratti, E., et al. TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 111 (2009), 1051–1061.
137. Nonhoff, U., Ralser, M., Welzel, F., Piccini, I., Balzereit, D., Yaspo, M.L., et al. Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. Mol. Biol. Cell 18 (2007), 1385–1396.
138. Moreira, M.C., Klur, S., Watanabe, M., Nemeth, A.H., Le Ber, I., Moniz, J.C., et al. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat. Genet. 36 (2004), 225–227.
139. Chen, Y.Z., Bennett, C.L., Huynh, H.M., Blair, I.P., Puls, I., Irobi, J., et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet. 74 (2004), 1128–1135.
140. Bassuk, A.G., Chen, Y.Z., Batish, S.D., Nagan, N., Opal, P., Chance, P.F., et al. In cis autosomal dominant mutation of senataxin associated with tremor/ataxia syndrome. Neurogenetics 8 (2007), 45–49.
141. Zhao, Z.H., Chen, W.Z., Wu, Z.Y., Wang, N., Zhao, G.X., Chen, W.J., et al. A novel mutation in the senataxin gene identified in a Chinese patient with sporadic amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 10 (2009), 118–122.
142. Hirano, M., Quinzii, C.M., Mitsumoto, H., Hays, A.P., Roberts, J.K., Richard, P., et al. Senataxin mutations and amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 12 (2011), 223–227.
143. Rudnik-Schoneborn, S., Arning, L., Epplen, J.T., Zerres, K., SETX gene mutation in a family diagnosed autosomal dominant proximal spinal muscular atrophy. Neuromuscul. Disord. 22 (2012), 258–262.
144. Saracchi, E., Castelli, M., Bassi, M.T., Brighina, E., Cereda, D., Marzorati, L., et al. A novel heterozygous SETX mutation in a patient presenting with chorea and motor neuron disease. Amyotroph. Lateral Scler. Frontotemporal Degener. 15 (2014), 138–140.
145. Mancini, C., Orsi, L., Guo, Y., Li, J., Chen, Y., Wang, F., et al. An atypical form of AOA2 with myoclonus associated with mutations in SETX and AFG3L2. BMC Med. Genet., 16, 2015, 16.
146. Steinmetz, E.J., Conrad, N.K., Brow, D.A., Corden, J.L., RNA-binding protein Nrd1 directs poly(A)-independent 3′-end formation of RNA polymerase II transcripts. Nature 413 (2001), 327–331.
147. Steinmetz, E.J., Warren, C.L., Kuehner, J.N., Panbehi, B., Ansari, A.Z., Brow, D.A., Genome-wide distribution of yeast RNA polymerase II and its control by Sen1 helicase. Mol. Cell 24 (2006), 735–746.
148. Mischo, H.E., Gomez-Gonzalez, B., Grzechnik, P., Rondon, A.G., Wei, W., Steinmetz, L., et al. Yeast Sen1 helicase protects the genome from transcription-associated instability. Mol. Cell 41 (2011), 21–32.
149. Becherel, O.J., Yeo, A.J., Stellati, A., Heng, E.Y., Luff, J., Suraweera, A.M., et al. Senataxin plays an essential role with DNA damage response proteins in meiotic recombination and gene silencing. PLoS Genet., 9, 2013, e1003435.
150. Alzu, A., Bermejo, R., Begnis, M., Lucca, C., Piccini, D., Carotenuto, W., et al. Senataxin associates with replication forks to protect fork integrity across RNA-polymerase-II-transcribed genes. Cell 151 (2012), 835–846.
151. Yuce, O., West, S.C., Senataxin, defective in the neurodegenerative disorder ataxia with oculomotor apraxia 2, lies at the interface of transcription and the DNA damage response. Mol. Cell. Biol. 33 (2013), 406–417.
152. Richard, P., Feng, S., Manley, J.L., A SUMO-dependent interaction between senataxin and the exosome, disrupted in the neurodegenerative disease AOA2, targets the exosome to sites of transcription-induced DNA damage. Genes Dev. 27 (2013), 2227–2232.
153. Richard, P., Manley, J.L., SETX sumoylation: a link between DNA damage and RNA surveillance disrupted in AOA2. Rare Dis. 2:1 (Jan.–Dec. 2014), 1–6.
154. Yeo, A.J., Becherel, O.J., Luff, J.E., Cullen, J.K., Wongsurawat, T., Jenjaroenpoon, P., et al. R-loops in proliferating cells but not in the brain: implications for AOA2 and other autosomal recessive ataxias. PLoS One, 9(3), Mar. 17 2014, e90219.
155. Balk, B., Maicher, A., Dees, M., Klermund, J., Luke-Glaser, S., Bender, K., et al. Telomeric RNA–DNA hybrids affect telomere-length dynamics and senescence. Nat. Struct. Mol. Biol. 20 (2013), 1199–1205.
156. Pfeiffer, V., Crittin, J., Grolimund, L., Lingner, J., The THO complex component Thp2 counteracts telomeric R-loops and telomere shortening. EMBO J. 32 (2013), 2861–2871.
157. De Amicis, A., Piane, M., Ferrari, F., Fanciulli, M., Delia, D., Chessa, L., Role of senataxin in DNA damage and telomeric stability. DNA Repair 10 (2011), 199–209.
158. Kaneko, S., Rozenblatt-Rosen, O., Meyerson, M., Manley, J.L., The multifunctional protein p54nrb/PSF recruits the exonuclease XRN2 to facilitate pre-mRNA 3′ processing and transcription termination. Genes Dev. 21 (2007), 1779–1789.
159. West, S., Gromak, N., Proudfoot, N.J., Human 5′ -> 3′ exonuclease Xrn2 promotes transcription termination at co-transcriptional cleavage sites. Nature 432 (2004), 522–525.
160. Morales, J.C., Richard, P., Patidar, P.L., Motea, E.A., Dang, T.T., Manley, J.L., et al. XRN2 links transcription termination to DNA damage and replication stress. PLoS Genet., 12, 2016, e1006107.
161. Rice, G., Patrick, T., Parmar, R., Taylor, C.F., Aeby, A., Aicardi, J., et al. Clinical and molecular phenotype of Aicardi–Goutieres syndrome. Am. J. Hum. Genet. 81 (2007), 713–725.
162. Lim, Y.W., Sanz, L.A., Xu, X., Hartono, S.R., Chedin, F., Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi–Goutieres syndrome. eLife, 4, 2015.
163. Lee-Kirsch, M.A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y.A., et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 39 (2007), 1065–1067.
164. Gunther, C., Kind, B., Reijns, M.A., Berndt, N., Martinez-Bueno, M., Wolf, C., et al. Defective removal of ribonucleotides from DNA promotes systemic autoimmunity. J. Clin. Invest. 125 (2015), 413–424.
165. Dykens, E.M., Lee, E., Roof, E., Prader–Willi syndrome and autism spectrum disorders: an evolving story. J. Neurodev. Disord. 3 (2011), 225–237.
166. Chamberlain, S.J., Lalande, M., Angelman syndrome, a genomic imprinting disorder of the brain. J. Neurosci. 30 (2010), 9958–9963.
167. Cassidy, S.B., Schwartz, S., Miller, J.L., Driscoll, D.J., Prader–Willi syndrome. Genet. Med. 14 (2012), 10–26.
168. Sahoo, T., del Gaudio, D., German, J.R., Shinawi, M., Peters, S.U., Person, R.E., et al. Prader–Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat. Genet. 40 (2008), 719–721.
169. El Achkar, E., Gerbault-Seureau, M., Muleris, M., Dutrillaux, B., Debatisse, M., Premature condensation induces breaks at the interface of early and late replicating chromosome bands bearing common fragile sites. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 18,069–18,074.
170. Wahba, L., Gore, S.K., Koshland, D., The homologous recombination machinery modulates the formation of RNA–DNA hybrids and associated chromosome instability. eLife, 2, 2013, e00505.